SL PHARM(002038.SZ)

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People’s Republic of China and internationally. The company’s finished formulations include temozolomide; arsenic trioxide; lenalidomide capsules; pegylated human granulocyte-stimulating factor injection; human granulocyte-cell stimulating factor injection; recombinant human basic fibroblast growth factor for external use recombinant human basic fibroblast growth factor gel; human interleukin-11; arsenic trioxide; thymopentin; paclitaxel injection; docetaxel injection; vinorelbine tartrate injection; asparaginase; calcium folinate; gemcitabine hydrochloride; regorafenib tablets; oseltamivir phosphate capsules; ornidazole injection; adefovir dipivoxil capsules/adefovir dipivoxil tablets; ribavirin; valacyclovir hydrochloride; levofloxacin hydrochlorid; tenofovir disoproxil fumarate; cyclosporin injection/cyclosporin soft capsules; mycophenolate mofetil dispersible; coenzyme complex; enoxaparin sodium; simvastatin; telmisartan amlodipine; liposon; nitroglycerin spray; eptifibatide, argatroban; voglibose; dapagliflozin; vildagliptin; granisetron hydrochloride injection; omeprazole enteric-coated capsules; adenosylmethionine butanedisulfonate; cytidine triphosphate disodium injection cytidine triphosphate disodium injection; gabapentin; risedronate sodium; salmon calcitonin injection; lucosamine sulfate capsules; loratadine dispersible; desloratadine; naftopidil; somatostatin for injection; octreotide acetate; and etodolac sustained-release tablets. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998.